| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/21/2007 | US20070142628 Useful in development of antibodies that recognize 6-monoacetyl morphine (6-MAM) and 6-monoacetyl codeine (6-MAC) and in production of conjugates useful in immunoassay |
| 06/21/2007 | US20070142626 Cross-linking reagents for hemoglobin and hemoglobin products cross-linked therewith |
| 06/21/2007 | US20070142625 Virus filtration of liquid Factor VII compositions |
| 06/21/2007 | US20070142624 Purifying lectin Concanavalin A (Con A) using a buffer in which impurities, such as glycogen and other substances are soluble, but in which the protein remains insoluble |
| 06/21/2007 | US20070142623 Protein expression system |
| 06/21/2007 | US20070142622 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 06/21/2007 | US20070142299 Compositions and methods for regulating apoptosis |
| 06/21/2007 | US20070142295 Thrombopoietic compounds |
| 06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
| 06/21/2007 | US20070142292 Stimulates production of macrophage inflammatory protein from hepatocytes; metal chelator; inhibits bacterial growth |
| 06/21/2007 | US20070142290 Surface-modified serum albumin-metal porphyrin composite, and oxygen infusion solution containing the same |
| 06/21/2007 | US20070142288 Isolated MCPIP and methods of use |
| 06/21/2007 | US20070142284 Vascular endothelial cell growth factor variants and uses thereof |
| 06/21/2007 | US20070142282 Modified VEGF-A with improved angiogenic properties |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | US20070142278 Muteins of fibroblast growth factor 21 |
| 06/21/2007 | US20070142277 Bace455, an alternative splice variant of the human beta-secretase |
| 06/21/2007 | US20070142276 Protein involved in carcinoma |
| 06/21/2007 | US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression |
| 06/21/2007 | US20070141708 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 06/21/2007 | US20070141694 Sequestering Of Glycoprotein Molecules and Oligosaccharide Moieties In Lipo-Glycoprotein Membranes and Micelles |
| 06/21/2007 | US20070141676 Cytokine protein family |
| 06/21/2007 | US20070141675 Process for producing glycoprotein |
| 06/21/2007 | US20070141674 Host cells and culture methods |
| 06/21/2007 | US20070141672 Minimalist bZIP Proteins and uses thereof |
| 06/21/2007 | US20070141671 canine interleukin -5 protein for use in identifying immunomodulators which treat or prevent autoimmune, allergic, infectious, inflammatory and graft rejection disorders in animals |
| 06/21/2007 | US20070141670 Mammalian cytokine-like polypeptide-10 |
| 06/21/2007 | US20070141666 Leader sequences for use in production of proteins |
| 06/21/2007 | US20070141665 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 06/21/2007 | US20070141663 Process for the preparation of copolymer-1 |
| 06/21/2007 | US20070141662 Fusion proteins and methods of cleavage of such proteins |
| 06/21/2007 | US20070141648 Flj10607 as modifier of the axin pathway and methods of use |
| 06/21/2007 | US20070141644 G protein coupled receptor specific immunoglobulin for use in treatment and prevention of cell proliferative, cardiovascular and metabolic disorders |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070141642 Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37 |
| 06/21/2007 | US20070141640 a polynucleotide comprising a nucleotide sequence that codes for a sodium channel protein having an amino acid sequence in which one or more amino acids differs from the amino acids in the wild-type protein by replacements, used for screening compounds for use as antiarrhythmic agents |
| 06/21/2007 | US20070141634 Assay |
| 06/21/2007 | US20070141619 Drug resistance-associated gene and use thereof |
| 06/21/2007 | US20070141609 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3) |
| 06/21/2007 | US20070141608 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 06/21/2007 | US20070141607 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 06/21/2007 | US20070141606 Nucleotide sequences coding polypeptide for use ias diagnostic tool in genetic engineering; proteins that are colored and/or fluorescent, where this feature arises from the interaction of two or more residues of the protein |
| 06/21/2007 | US20070141600 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 06/21/2007 | US20070141590 Modulators of tissue regeneration |
| 06/21/2007 | US20070141579 MUM-1 protein expressed by multiple myeloma-related gene |
| 06/21/2007 | US20070141578 LuxO-sigma54 interactions and methods of use |
| 06/21/2007 | US20070141573 Complement inhibitors |
| 06/21/2007 | US20070141569 Splice variant of human placental growth hormone |
| 06/21/2007 | US20070141566 Methods and materials relating to novel polypeptides and polynucleotides |
| 06/21/2007 | US20070141554 Stable cell lines expressing hERG |
| 06/21/2007 | US20070141551 pH-sensing dye comprises 2-[1E,3E)-5-(3-methyl-3-(5-carboxypentyl)-5-sulfo-1,3-dihydro-2H-indol-2-ylidene)-1,3-pentadienyl]-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium covalently bound to a lipoprotein; high-throughput assays |
| 06/21/2007 | US20070141088 Glucan-based vaccines |
| 06/21/2007 | US20070141087 Compounds and methods for diagnosis of tuberculosis |
| 06/21/2007 | US20070141085 Recombinant protective protein from Streptococcus pneumoniae |
| 06/21/2007 | US20070141084 Polysaccharide-protein conjugate vaccines |
| 06/21/2007 | US20070141082 Cell surface expression vector of parvovirus antigen and microorganisms transformed thereof |
| 06/21/2007 | US20070141081 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
| 06/21/2007 | US20070141077 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 06/21/2007 | US20070141076 Antigen fragments for the diagnosis of Toxoplasma gondii |
| 06/21/2007 | US20070141075 Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays |
| 06/21/2007 | US20070141072 Use of multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 06/21/2007 | US20070141068 Methods for the treatment of carcinoma |
| 06/21/2007 | US20070141065 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation |
| 06/21/2007 | US20070141064 Fully human hybridoma fusion partner cell lines |
| 06/21/2007 | US20070141063 Peptide having ability to activate cancer-related gene |
| 06/21/2007 | US20070141061 Protein involved in carcinoma |
| 06/21/2007 | US20070141057 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/21/2007 | US20070141056 Growth factor homolog zvegf3 |
| 06/21/2007 | US20070141051 Nucleic acid encoding cytokine receptor zcytor17 |
| 06/21/2007 | US20070141028 Cancer gene therapeutic drug |
| 06/21/2007 | US20070141025 Compositions and methods for cancer immunotherapy |
| 06/21/2007 | US20070141024 Mammalian cytokine; reagents and methods |
| 06/21/2007 | US20070141021 Methylmaleimidyl polymer derivatives |
| 06/21/2007 | US20070140972 Targeting compositions and preparation therof |
| 06/21/2007 | US20070140970 Cell targeting conjugates |
| 06/21/2007 | US20070140964 Cytokine receptor zcytor17 multimers |
| 06/21/2007 | US20070140963 Cytokine receptor zcytor17 multimers |
| 06/21/2007 | US20070140962 Light Sensitive Compounds for Instant Determination of Organ Function |
| 06/21/2007 | DE102005060920A1 Peptide für die Wechselwirkung mit alpha-helikalen Coiled-Coil-Strukturen und/oder Coiled-Coil-Sequenzen, davon abgeleitete Mittel und ihre Verwendung Peptides for interaction with alpha-helical coiled-coil structures and / or the coiled-coil sequences derived therefrom and their use |
| 06/21/2007 | CA2633468A1 Novel neurotrophic factor protein and uses thereof |
| 06/21/2007 | CA2633296A1 Method of detecting and reducing boar taint using nuclear receptors |
| 06/21/2007 | CA2632451A1 Cell penetrating peptides for intracellular delivery of molecules |
| 06/21/2007 | CA2632142A1 Nuclear reprogramming factor |
| 06/21/2007 | CA2630811A1 Improved production of glycoproteins using manganese |
| 06/21/2007 | CA2627939A1 New chemokine antagonists |
| 06/21/2007 | CA2627176A1 Polynucleotides and polypeptide of human kv1.3, compositions comprising same and methods of using same |
| 06/20/2007 | EP1798556A1 Device for the early and rapid immunochromatographic detection of HIV and uses thereof |
| 06/20/2007 | EP1798288A2 Human Toll-like receptor proteins, related reagents and methods |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798241A1 Method of manufacturing a hapten between doxycycline and bovine serum albumin and application for detecting doxycycline in humans or animals |
| 06/20/2007 | EP1798240A1 Recombinant triplex scaffold-based polypeptides |
| 06/20/2007 | EP1798239A2 G-protein coupled receptors and uses therefor |
| 06/20/2007 | EP1797894A2 Vaccine composition |
| 06/20/2007 | EP1797754A1 Transcription factor stress-related proteins and methods of use in plants |
| 06/20/2007 | EP1797192A1 Modified proteins |
| 06/20/2007 | EP1797186A1 Expression system, components thereof and methods of use |
| 06/20/2007 | EP1797173A2 Modulation of replicative fitness by using less frequently used synonymous codons |
| 06/20/2007 | EP1797127A2 Modified fc molecules |
| 06/20/2007 | EP1797124A1 Covalent grafting of hydrophobic substances on collagen |